The American College of Radiation Oncology Summit Meeting

January 8, 2024 — Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.

January 8, 2024 — Qure.ai, a leading global innovator in medical imaging solutions, has announced its 13th FDA clearance for their AI-enabled solutions.

January 8, 2024 — GE HealthCare announced it has entered into an agreement to acquire MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide

January 5, 2024 — NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. (Curadh), a global MTR-focused clinical, research and advisory organization, today announced a long-term strategic collaboration to develop and produce novel radiopharmaceuticals for the diagnosis and treatment

As another year has come to a close, the Imaging Technology News (ITN) team reflects back on the Top 10 topics that our viewers were focused on in 2023

As another year has come to a close, the Imaging Technology News (ITN) team reflects back on the Top 10 topics that our viewers were focused on in 2023.

1. MRI Meets AI

2. A Look at the Changes in 2023 to Radiology and IR CPT Codes

January 4, 2024 — Diagnosing cancer today involves using chemical “contrast agents” to improve the accuracy of medical imaging processes such as X-rays as well as computed tomography (CT) and magnetic resonance imaging (MRI) scans. 

But those agents can be expensive, take more time to use and pose potential health concerns.

January 4, 2024 — Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now